EP Patent

EP1732524A2 — Methods and compositions for treatment of ion imbalances

Assigned to Relypsa Inc · Expires 2006-12-20 · 19y expired

What this patent protects

The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium­binding polymers and pharmaceutical compositions thereof Methods of use of the polymeric and pharmaceutical compositio…

USPTO Abstract

The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium­binding polymers and pharmaceutical compositions thereof Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.

Drugs covered by this patent

Patent Metadata

Patent number
EP1732524A2
Jurisdiction
EP
Classification
—
Expires
2006-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Relypsa Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.